GlobalResearch and clinical trials
Once-weekly growth hormone as effective as daily injections in Turner syndrome in a phase 3 trial
Once-weekly growth hormone was tested in girls with Turner syndrome.
Hormone and bone diseases
A chromosome difference seen only in girls. One of the two X chromosomes is missing or incomplete. The most common signs are short stature and ovaries that do not work well.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Hormone and bone diseases” group.
Girls normally have two X chromosomes. In Turner syndrome, one of them is completely or partly missing. Sometimes this difference is found only in some cells; this is called mosaicism. Growth and the ovaries are affected the most. Intelligence is usually normal.
Each girl can have different symptoms.
The diagnosis is made with a blood test that counts the chromosomes. The condition can be noticed at birth, in childhood or in adolescence. It can also be found with tests done during pregnancy after ultrasound findings. The heart, kidneys and hormones are also examined.
There is no treatment that removes the condition, but support is good. Hormone treatment helps growth and puberty. Blood pressure, thyroid, bone density and the heart are followed up regularly. Learning support and psychological support are given when needed. For those who want to have children, options such as IVF can be discussed. The doctor who follows the disease decides which treatment is suitable.
It is usually not inherited. The difference happens by chance when the egg or sperm cells are formed or at the start of pregnancy. It has nothing to do with the parents' age or anything they did. Very rarely, a partial loss in the X chromosome can be passed on in the family. You can get genetic counselling for your questions.
Source: NHS: Turner syndrome · MedlinePlus Genetics: Turner syndrome · MedlinePlus: Turner syndrome
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
GlobalResearch and clinical trials
Once-weekly growth hormone was tested in girls with Turner syndrome.
TürkiyeResearch and clinical trials
In Diyarbakır, 48 Turner patients who received growth hormone and reached their final height were studied.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 17 active interventional studies for this disease. 8 are recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Late stage: the effect is being compared in a large group · Phase 3 · investigational (experimental)RecruitingNCT07221851
Late stage: the effect is being compared in a large group · Phase 3 · investigational (experimental)RecruitingNCT07614152
Middle stage: the effect is being tested in a small group · Phase 2 · investigational (experimental)Not yet recruitingNCT07784582
Late stage: the effect is being compared in a large group · Phase 3 · investigational (experimental)Active, not recruitingNCT05723835
Late stage: the effect is being compared in a large group · Phase 3 · investigational (experimental)Active, not recruitingNCT05330325
See all studies on ClinicalTrials.gov · Joining clinical trials
GlobalResearch and clinical trials
The trial included 63 adults from 16 countries.
TürkiyeResearch and clinical trials
At Bursa Uludağ University, the move of 29 young people with CAH (congenital adrenal hyperplasia) from pediatric to adult doctors was studied.
TürkiyeDiagnosis and screening
In Sultanbeyli, Istanbul, the screening of 5,934 babies for CAH (congenital adrenal hyperplasia) over one year was reviewed.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:881 · ICD-11 LD50.0
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.